COMMUNIQUÉS West-GlobeNewswire

Collegium Reports Second Quarter Financial Results and Provides Corporate Update
08/08/2018
Net revenue $73.1 million for the second quarter of 2018, 1,952% increase vs second quarter 2017, 15% vs first quarter 2018 Xtampza ER prescriptions grew by 23% in the second quarter of 2018 Cash balance at end of 2018 [...]
Celldex Provides Corporate Update and Reports Second Quarter 2018 Results
08/08/2018
HAMPTON, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2018. The Company will host a conference [...]
Chembio Diagnostics Reports Second Quarter 2018 Financial Results
08/08/2018
MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic testing, today reported financial results for the second quarter ended June 30, 2018. [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress
08/08/2018
SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes [...]
Reata Pharmaceuticals, Inc. Announces Second Quarter 2018 Financial Results and an Update on Development Programs
08/08/2018
IRVING, Texas, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company's product development programs and [...]
G1 Therapeutics Provides Second Quarter 2018 Corporate and Financial Update
08/08/2018
Presenting additional data from randomized Phase 2 trilaciclib/chemotherapy trial in first-line small cell lung cancer at ESMO 2018 in October Initiated Phase 2a enrollment of lerociclib (G1T38) in ER+, HER2- breast [...]
Ziopharm Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update
08/08/2018
Company Focused on Responding to FDA for Third-generation Trial NCI to file IND for Sleeping Beauty Manufactured TCR-T Cell Therapies Targeting Neoantigens in 4Q2018 Controlled IL-12 Monotherapy, Combination Studies [...]
Foamix Reports Second Quarter 2018 Financial Results and Provides Corporate Update
08/08/2018
REHOVOT, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]
Mersana Therapeutics to Host Conference Call Announcing Second Quarter 2018 Financial Results and Business Updates
08/08/2018
CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene Therapy Talent and Tools
08/08/2018
-- Sarepta expands its presence in gene therapy and broadens its reach with license to up to three new CNS-targeted gene therapy programs, including exclusive rights to Lacerta’s gene therapy candidate for Pompe Disease [...]
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
08/08/2018
-- Completed Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Pro-opiomelanocortin (POMC) and Leptin Receptor (LEPR) Deficiency Obesity -- -- Announced New Topline Clinical Data from [...]
Spring Bank Announces Proposed Public Offering of Common Stock
08/08/2018
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced that it intends to offer and sell, subject to market conditions, shares of its common [...]
FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
08/08/2018
-- Positive vote for both the skin infections and pneumonia indications -- -- FDA decision expected in early October 2018 -- BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today [...]
Tetra Bio-Pharma’s Dr. Chamberland to Announce Health Canada’s Green Light for the Cannabis vs. Fentanyl Trial
08/08/2018
ORLEANS, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Health Canada has [...]
SPINEWAY : Ordinary and Extraordinary General Shareholders' Meeting of 13 September Access to preparatory documentation
08/08/2018
Press release Ecully, 8 August 2018 Ordinary and Extraordinary General Shareholders' Meeting of 13 September Access to preparatory documentation The shareholders of SPINEWAY are invited to attend the Ordinary and [...]
SPINEWAY : Assemblée Générale mixte du 13 septembre Mise à disposition des documents préparatoires
08/08/2018
Communiqué de presse Ecully, le 8 août 2018 Assemblée Générale mixte du 13 septembre Mise à disposition des documents préparatoires Les actionnaires de la société SPINEWAY sont invités à participer à l'Assemblée [...]
Bavarian Nordic to Host First Half 2018 Results Conference Call
08/08/2018
COPENHAGEN, Denmark - August 8 , 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 first half results on Thursday, August 16, 2018. The management of Bavarian Nordic will host a conference call [...]
Yun Yen, MD, PhD and Winson (Sze Chun) Ho, MD Join Lixte Biotechnology’s Board of Directors
08/08/2018
EAST SETAUKET, NY, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced today the appointments of two new members to the Board of Directors of Lixte: Yun Yen, MD, PhD and Winson ( [...]
The Alliance for Regenerative Medicine Releases Q2 2018 Data Report, Highlighting Sector Trends and Metrics
08/08/2018
WASHINGTON, D.C., Aug. 08, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue [...]

Pages